|
ZNF230 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.17440002167513E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.73629999056635E-09 |
| Normal-vs-Stage2 |
1.48070000038913E-07 |
| Normal-vs-Stage3 |
2.61390020739327E-10 |
| Normal-vs-Stage4 |
2.02650007885552E-10 |
| Stage1-vs-Stage2 |
9.408600E-01 |
| Stage1-vs-Stage3 |
7.514400E-02 |
| Stage1-vs-Stage4 |
6.008400E-02 |
| Stage2-vs-Stage3 |
2.777200E-01 |
| Stage2-vs-Stage4 |
1.680230E-01 |
| Stage3-vs-Stage4 |
6.523400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.86160034241357E-10 |
| Normal-vs-AfricanAmerican |
1.041930E-04 |
| Normal-vs-Asian |
8.47469999731842E-08 |
| Caucasian-vs-AfricanAmerican |
5.507400E-01 |
| Caucasian-vs-Asian |
4.077400E-01 |
| AfricanAmerican-vs-Asian |
9.918600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.73479999441429E-09 |
| Normal-vs-Female |
8.65050031606529E-10 |
| Male-vs-Female |
4.070800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.38550001974147E-09 |
| Normal-vs-Age(41-60Yrs) |
3.54990004058919E-09 |
| Normal-vs-Age(61-80Yrs) |
7.01189994956053E-10 |
| Normal-vs-Age(81-100Yrs) |
1.615690E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.425000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.171800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.173800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.265000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.483400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.744000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.442500E-04 |
| Classical-VS-Follicular |
4.683600E-01 |
| Classical-VS-Other |
9.996600E-01 |
| Classical-VS-Normal |
2.14440000201321E-08 |
| Tall-VS-Follicular |
1.536120E-02 |
| Tall-VS-Other |
3.216000E-01 |
| Tall-VS-Normal |
1.60099711266071E-11 |
| Follicular-VS-Other |
8.331600E-01 |
| Follicular-VS-Normal |
2.01190000215234E-08 |
| Other-VS-Normal |
2.057900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.66989999395417E-09 |
| Normal-vs-N1 |
2.40309994126164E-10 |
| N0-vs-N1 |
7.984000E-02 |
|
|
